The latest closing stock price for InMed Pharmaceuticals as of November 21, 2024 is 4.65.
An investor who bought $1,000 worth of InMed Pharmaceuticals stock at the IPO in 2020 would have $-943 today, roughly -1 times their original investment - a -51.09% compound annual growth rate over 4 years.
The all-time high InMed Pharmaceuticals stock closing price was 133.75 on February 11, 2021.
The InMed Pharmaceuticals 52-week high stock price is 5.41, which is 16.3% above the current share price.
The InMed Pharmaceuticals 52-week low stock price is 0.12, which is 97.4% below the current share price.
The average InMed Pharmaceuticals stock price for the last 52 weeks is 0.40.
An investor who bought $1,000 worth of InMed Pharmaceuticals stock at the IPO in 2020 would have $-943 today, roughly -1 times their original investment - a -51.09% compound annual growth rate over 4 years.
The all-time high InMed Pharmaceuticals stock closing price was 133.75 on February 11, 2021.
The InMed Pharmaceuticals 52-week high stock price is 5.41, which is 16.3% above the current share price.
The InMed Pharmaceuticals 52-week low stock price is 0.12, which is 97.4% below the current share price.
The average InMed Pharmaceuticals stock price for the last 52 weeks is 0.40.